{
    "organizations": [],
    "uuid": "b9782bafe94e0b3b5ac8620d1df1d70894d1c54e",
    "author": "",
    "url": "https://www.reuters.com/article/brief-rigel-pharmaceuticals-says-expects/brief-rigel-pharmaceuticals-says-expects-to-report-about-94-3-mln-cash-cash-equivalents-short-term-investments-as-of-march-31-2018-idUSFWN1RX0ZU",
    "ord_in_thread": 0,
    "title": "BRIEF-Rigel Pharmaceuticals Says Expects To Report About $94.3 Mln Cash, Cash Equivalents, Short-Term Investments As Of March 31, 2018",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Market News April 20, 2018 / 8:29 PM / Updated 12 minutes ago BRIEF-Rigel Pharmaceuticals Says Expects To Report About $94.3 Mln Cash, Cash Equivalents, Short-Term Investments As Of March 31, 2018 Reuters Staff 1 Min Read \nApril 20 (Reuters) - Rigel Pharmaceuticals Inc: \n* RIGEL PHARMACEUTICALS SAYS EXPECTS TO REPORT IT HAD ABOUT $94.3 MILLION CASH, CASH EQUIVALENTS, SHORT-TERM INVESTMENTS AS OF MARCH 31, 2018 - SEC FILING Source text: ( bit.ly/2Jedbsn ) Further company coverage:",
    "published": "2018-04-20T23:29:00.000+03:00",
    "crawled": "2018-04-20T23:53:25.036+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "market",
        "news",
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "say",
        "expects",
        "report",
        "mln",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "march",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "rigel",
        "pharmaceutical",
        "inc",
        "rigel",
        "pharmaceutical",
        "say",
        "expects",
        "report",
        "million",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "march",
        "sec",
        "filing",
        "source",
        "text",
        "company",
        "coverage"
    ]
}